The amount of information that is becoming available is vast. In a recent SSF meeting in USA  there were 10,000 (TEN THOUSAND) Rheumatologists and researchers in attendance. Sjogren’s is continuing to receive considerably more recognition and attention from practicing reheumatologists and researchers as well as potential corporate partners looking to develop clinical trials and biologic … Continue reading Ideas on spreading the News